Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1245/s10434-013-2955-0.pdf
Reference16 articles.
1. Fisher ER, Palekar AS, Sass R, Fisher B. Scar cancers: pathologic findings from the national surgical adjuvant breast project (protocol no. 4): IX. Breast Cancer Res Treat. 1983;3(1):39–59.
2. Hasebe T, Mukai K, Tsuda H, Ochiai A. New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus. Pathol Int. 2000;50(4):263–72.
3. Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn J Cancer Res. 1996;87(4):385–94.
4. Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol. 2002;15(5):502–16.
5. Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat. 1998;49(3):195–208.
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome;Breast Cancer Research;2024-09-02
2. Integrative analysis identifies molecular features of fibroblast and the significance of fibrosis on neoadjuvant chemotherapy response in breast cancer;International Journal of Surgery;2024-03-28
3. Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations;Journal of Drug Delivery Science and Technology;2024-03
4. Current status and future prospective of breast cancer immunotherapy;Advances in Protein Chemistry and Structural Biology;2024
5. Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer;Breast Cancer Research and Treatment;2023-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3